{
    "organizations": [],
    "uuid": "ba3168a3b17365461ed843f1fb827d3b460fb5e3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mabvax-therapeutics-regains-compli/brief-mabvax-therapeutics-regains-compliance-with-nasdaqs-1-00-minimum-bid-price-maintenance-requirement-idUSFWN1QO0G2",
    "ord_in_thread": 0,
    "title": "BRIEF-MabVax Therapeutics Regains Compliance With NASDAQ's $1.00 Minimum Bid Price Maintenance Requirement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Mabvax Therapeutics Holdings Inc :\n* MABVAX THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQâ€™S $1.00 MINIMUM BID PRICE MAINTENANCE REQUIREMENT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T22:18:00.000+02:00",
    "crawled": "2018-03-07T19:29:15.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "mabvax",
        "therapeutic",
        "holding",
        "inc",
        "mabvax",
        "therapeutic",
        "regains",
        "compliance",
        "nasdaq",
        "minimum",
        "bid",
        "price",
        "maintenance",
        "requirement",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}